Nursing Alchemy: Transforming R-CHOP Information Into Essentials

Alexandra K. Sakowski

Puja R. Patel

diffuse large B-cell lymphoma, R-CHOP, chemotherapy side effects
CJON 2023, 27(5), 553-564. DOI: 10.1188/23.CJON.553-564

A combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is a first-line combination chemotherapy regimen for diffuse large B-cell lymphoma that has many nursing implications. Understanding the mechanisms of these chemotherapy agents helps in understanding the administration and management of clinical care.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.